Dr. Satheesh Elangovan, OF Basic Science Grant Awardee
Dr. Elangovan joined the University of Iowa College of Dentistry Department of Periodontics in 2011 after completing his doctor of medical science at Harvard School of Dental Medicine and his postdoctoral research fellow at the Forsyth Institute, both in Boston. Dr. Elangovan holds secondary appointments at the College of Engineering and at the College of Pharmacy.
Each year, AO members, faculty members and students who conduct research in any academic dental institution (where at least one person on the research team is an AO member) have a premier opportunity to be eligible for as much as $30,000 in research grants via the AO/OF Research Grant program.
Those who are selected as first-place grant recipients then present their results at the subsequent AO Annual Meeting, and submit a research manuscript to AO’s official journal – the International Journal of Oral and Maxillofacial Implants (JOMI) – the leading and frequently cited global publication of implant dentistry.
At AO’s 2017 Annual Meeting, Satheesh Elangovan, BDS, DSc, DMSc, along with his team from the University of Iowa, was selected as the First Place Basic Science recipient for their submission, “A Novel Gene Activated Barrier Membrane that Harnesses the Regenerative Potential of Periosteum.”
“Our research team at the University of Iowa College of Dentistry is very grateful to the Osseointegration Foundation for this grant support that will allow us to explore the bone regeneration efficacy of a novel bioactive barrier membrane which has immense clinical translational potential,” said Dr. Elangovan.
Dr. Elangovan’s research focuses on developing novel strategies to deliver plasmid DNA or chemically modified RNA of growth factors with the goal of enhancing tissue healing or regeneration. The specific goal of this project is to create a bioactive resorbable barrier membrane that can deliver plasmid DNA (encoding a bone regenerative factor) at the implanted site.
According to Dr. Elangovan, following the release of plasmid DNA the host cells at the implanted site take up the DNA, synthesize and release the factor of interest (locally) that in turn enhances bone regeneration. In this project, Dr. Elangovan and his team are also evaluating a method to harness the regenerative potential of the periosteum.
“We are extremely thankful to the Foundation for supporting our project and I am looking forward to presenting the results at AO’s 2018 meeting,” he concluded.
Call for 2018-2019 OF Research Grants Now Open!
Interested in presenting your research? The Osseointegration Foundation recently announced it is currently accepting applications for 2018-2019 AO/OF Research Grants. First-place awardees will be required to present at AO’s 2019 Annual Meeting to be held March 14 – 16, 2019 in Washington, D.C. To read more about the Call, please CLICK HERE.